BioMarin

BioMarin

BioMarin

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem. Sign in

BioMarin

Address

Shanbally, N.A., Ireland

Contact

shanbally@bmrn.com

Description

The entity profile has not yet been completed.

This entity is yours?
Sign in to update information and position your organization seamlessly within the European bioproduction Value Chain. Benefit from the geolocated map to showcase your expertise, projects, and initiatives. Boost your visibility and make meaningful connections within the ecosystem.

Matchmaking

Connect with BioMarin

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

BioMarin last news

26/01/2024

GenEdit Tackles "Delivery, Delivery, Delivery" with Up-to-$644M Genentech Collaboration

The collaboration, which was announced on Tuesday, aims to develop non-viral, non-lipid, hydrophilic nanoparticles (HNPs) discovered through GenEdit's NanoGalaxy ® platform. NanoGalaxy includes a library consisting of thousands of unique non-viral, non-lipid, hydrophilic polymer nanoparticles. Using this combinatorial library of polymers, NanoGalaxy creates nanoparticles consisting of hydrophilic polymer backbones with diverse small-molecule side chains, all combined with a variety of structures to yield hundreds of thousands of structurally distinct polymers capable of targeting certain cells. The post GenEdit Tackles "Delivery, Delivery, Delivery" with Up-to-$644M Genentech Collaboration appeared first on GEN - Genetic Engineering and Biotechnology News .

26/01/2024

BioMarin Pharmaceutical Inc.'s (NASDAQ:BMRN) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum? - Simply Wall St News

[...] BioMarin Pharmaceutical's (NASDAQ:BMRN) stock is up by a considerable 13% over the past three months. We wonder if and what role the company's financials play in that price change as a company's long-term fundamentals usually dictate market outcomes. [...]

25/01/2024

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Shares Sold by Allworth Financial LP - MarketBeat

[...] Allworth Financial LP trimmed its position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN - Free Report) by 99.7% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investo [...]